Market Research Industry Reports

Feldan Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Feldan Therapeutics Inc (Feldan), formerly Feldan Bio Inc, is a biotechnology company with focus on the discovery, development, manufacture and marketing of recombinant proteins. The company developed a peptide-based technology platform, the Feldan Shuttle for intracellular delivery of proteins inside all cell types including human primary cells. Feldans pipeline of regenerative medicine therapeutic applications include FS-001, a Natural Killer (NK) cell-based immunotherapy program transmitting CRISPR nucleases in NK cells to eliminate viral-infected and tumor cells; FS-002, an intracellular antibody delivery program that targets intracellular proteins and regulates therapeutically relevant pathways. The company offers recombinant proteins, monoclonal antibodies and transfection reagents to life science companies and research laboratories. Feldan is headquartered in Quebec, Canada.

Feldan Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Feldan Bio Raises USD1.4 Million in Fourth Round of Financing 10
Partnerships 11
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 11
Elasmogen, Feldan Bio Enter into Agreement with Amgen 12
Feldan Bio and Elasmogen Enter into Development Partnership 13
Feldan Therapeutics Inc - Key Competitors 14
Feldan Therapeutics Inc - Key Employees 15
Feldan Therapeutics Inc - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Mar 29, 2018: CQDM will partner with Feldan to support a $1.2M project 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables

List of Tables
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Feldan Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Feldan Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Feldan Bio Raises USD1.4 Million in Fourth Round of Financing 10
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 11
Elasmogen, Feldan Bio Enter into Agreement with Amgen 12
Feldan Bio and Elasmogen Enter into Development Partnership 13
Feldan Therapeutics Inc, Key Competitors 14
Feldan Therapeutics Inc, Key Employees 15

List Of Figures

List of Figures
Atlantic Power Corporation, Performance Chart (2013 - 2017) 27
Atlantic Power Corporation, Ratio Charts 29
Atlantic Power Corporation, Power, Deals By Year, 2012 to YTD 2018 30
Atlantic Power Corporation, Power, Deals by Type, 2012 to YTD 2018 31

Feldan Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Feldan Therapeutics Inc (Feldan), formerly Feldan Bio Inc, is a biotechnology company with focus on the discovery, development, manufacture and marketing of recombinant proteins. The company developed a peptide-based technology

USD 250View Report

Feldan Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and

USD 250View Report

Frequency Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company which develops progenitor cell activation (PCA) therapies. The companys small molecule drugs are used to activate progenitor cells for restoration of

USD 250View Report

Appili Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :18
Country :Canada
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube